Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index decreasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.6%.
The iShares Biotechnology ETF (IBB) rose 2.1%.
In corporate news, IQVIA (IQV) shares fell 3.8% after Morgan Stanley downgraded the company to equalweight from overweight and cut its price target to $200 from $225.